Back

Corrigendum to: PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy

Cardiovascular Research

14 December 2021
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Enhancing autophagic flux via FYCO1 confers protection against adverse cardiac remodeling in response to myocardial ischemia
26 August 2023
thumbnail
Congress Presentation
Efficacy and safety of proprotein covertase subtilisin/kexin type 9 inhibitors among patients with acute coronary syndrome: a meta-analysis of randomized controlled trials
27 August 2022
thumbnail
Congress Presentation
Circulating markers of autophagy dysfunction are associated with coronary artery disease in patients undergoing coronary angiography
1 September 2025
thumbnail
Congress Presentation
Efficacy of PCSK9 inhibitors combined with statins versus statin monotherapy for secondary cardiovascular prevention: a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources